Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial. 

Pfizer will start COVID-19 vaccine trial in US next week

No takeover approach, says COVID-19 vaccine developer BioNTe...

Germany’s BioNTech has said it has not received any takeover approaches after it began a high-profile coronavirus vaccine trial with Pfizer in Germany, following press reports over the week

Pfizer, BioNTech aim to start German COVID-19 vaccine trial ...

BMS gets an important win for Opdivo combination in kidney c...

FDA approves Pfizer/Merck KGaA combo in advanced colorectal ...

The FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated metastatic colorectal cancer, the first targeted drug regimen for this form of the d